ProQR Therapeutics retweeted
On Sept 30 at 11a ET join our virtual Investor and Analyst educational event “NTCP Modulation in Biliary Atresia via Liver-Targeted RNA Editing”.
For additional information about the event and to register, visit: proqr.com/events
#Axiomer #RNAEditing @ProQR
ALT cover slide with text “NTCP Modulation in Biliary Atresia via Liver-Targeted RNA Editing” dated September 30, 2026
ProQR Therapeutics retweeted
veel stappen nodig voordat het echt iets kan gaan betekenen voor mensen met Rett syndroom in Nederland. Dit is in ieder geval een hoopvol begin dat wij graag ondersteunen!
ProQR Therapeutics retweeted
ProQR Therapeutics retweeted
Met een delegatie vanuit de NRSV bezochten we Proqr Therapeutics in Leiden. Een bedrijf in biotechnologie dat via RNA bewerking medicatie probeert te ontwikkelen voor ernstige zeldzame ziekten, zoals nu ook voor Rett syndroom. 🧵
bit.ly/43agfzH
ProQR Therapeutics retweeted
Explore some of the top #biotech companies in the Netherlands, which has established itself as a burgeoning biotech and #lifesciences hub 👇.
loom.ly/0_5LDEs
ProQR Therapeutics retweeted
It was nice to finally meet you in person, Andy Bolan at @UsherCoalition
#USH2022
I always enjoy hearing the latest updates with @ProQR
It's exciting knowing that research efforts have progressed to the point where we have final stage clinical trials for #UsherSyndrome – at Country Club, FL
ALT Andy (left) and Monica (right)
ProQR Therapeutics retweeted
We are so grateful to the sponsors of today’s Professionals’ Conference: @JanssenGlobal, @Novartis, @ProQR, @SantenGlobal and @AGTC_ #RetinaUKProfs
ProQR Therapeutics retweeted
Thank you to @ProQR for being a platinum level sponsor for this year’s #USH2022 Connections #Conference! We can’t wait to see you all July 8-9. Join us in person in Austin, TX, or online. Register here! #UsherSyndrome
usher-syndrome.org/ush2022.h…
ALT Usher Syndrome Coalition’s USH2022, a hybrid event, July 8-9 Austin, TX and online, post thanking ProQR for being a platinum level sponsor. ProQR Therapeutics- Striving to reverse blindness.
ProQR Therapeutics retweeted
InformedDNA, Foundation Fighting Blindness Partnership Will Screen Patients for Usher Syndrome, RP Clinical Trials bit.ly/36kz1eE #InformedDNA #Ushersyndrome #retinitispigmentosa #RP #clinicaltrials @fightblindness
ProQR Therapeutics retweeted
The Foundation is partnering with @ProQR and @InformedDNA to accelerate patient identification and enrollment in clinical research for people with #UsherSyndrome or non-syndromic #RetinitisPigmentosa due to mutations in exon 13 of the USH2A gene. fightingblindness.org/news/p…
ProQR Therapeutics retweeted
Welcome to #RareDiseaseDay, Europe! 🎉
There are over 300 million people who live with a rare disease in Europe.
With events taking place all over the continent, there's plenty to get involved in today!
How are you getting involved in #RareDiseaseDay in Europe?👇👇👇
ProQR Therapeutics retweeted
It's #WhiteCaneDay! To help raise awareness about white canes, we are sharing the amazing story of skateboarder Justin Bishop, who lost his vision quickly due to RP at 25. Ten years later, Justin is working to enhance accessibility in skateboarding. fightingblindness.org/resour…
ProQR Therapeutics retweeted
Our #EyeOnTheCurePodcast provides science insights from the world of vision, hosted by Ben Shaberman. This week, Dr. Naveed Shams, chief scientific officer at @ProQR, discusses RNA therapies and ProQR's three clinical trials targeting: LCA, USH2A, and RP. fightingblindness.org/podcas…
ALT Eye icon with sound waves above and text below that says, "Eye on the Cure, Foundation Fighting Blindness Podcast Series."
ProQR Therapeutics retweeted
Shout out to another of our #brilliant sponsors @ProQR for
supporting #UKEGG21 and helping make this whole event
possible through supporting research into therapeutics for
#InheritedRetinalDiseases
ProQR Therapeutics retweeted
Usher syndrome type 2 is usually moderate to severe bi lateral hearing loss from birth. In some, hearing loss may worsen over time. Onset of RP, night blindness & loss of peripheral vision begins late teens/early twenties. Peripheral vision loss is ongoing #UshDay21
ProQR Therapeutics retweeted
USHER AWARENESS DAY
Zaterdag 18 september a.s. Don't let the sun go down on USH. retweet en doneer 🧡
Help ons het doof én blind worden te stoppen. 🙏🏼Kom met ons in actie om achteruitgang van ons zicht en gehoor te stoppen. 🙏🏼 fb.watch/7YdxD9Ju7l/ #ushday #ushersyndroom
ProQR Therapeutics retweeted
Lilly To Try ProQR’s RNA-Editing Technology In Liver, Neurology Indications
bit.ly/3hk2wjj #PharmaScrip
ProQR Therapeutics retweeted
Eli Lilly will pay $50 million in upfront cash and equity and up to $1.25 billion in downstream milestones for access to five RNA editing candidates from Dutch biotech ProQR Therapeutics.
endpts.com/eli-lilly-takes-a…
ProQR Therapeutics retweeted
Our first condition-specific webinar is now available to watch back on our website. This session focuses on retinitis pigmentosa (RP), Leber congenital amaurosis (LCA), Usher syndrome, choroideremia, rod-cone dystrophy and retinal dystrophy.
ow.ly/mzjU50EH4Jm
ALT Retina 2020 graphic